VEGF has been found upregulated at the moderate stage of COVID-19 [106], and in COVID-19 patients compared to healthy controls; however, it was unable to predict the appearance of pulmonary embolism during hospitalisation [107]. This evidence concerns the gene VEGFA and COVID-19.